Conference on Retroviruses and Opportunistic Infections 2017 highlights

AIDS. 2017 Jun 19;31(10):N13-N16. doi: 10.1097/QAD.0000000000001490.
No abstract available

Publication types

  • Congress

MeSH terms

  • AIDS-Related Opportunistic Infections / diagnosis*
  • AIDS-Related Opportunistic Infections / drug therapy*
  • Amides
  • Anti-HIV Agents / adverse effects*
  • Anti-HIV Agents / therapeutic use*
  • Cardiovascular Diseases / chemically induced
  • Cardiovascular Diseases / epidemiology
  • Clinical Trials, Phase II as Topic
  • Darunavir / adverse effects
  • Darunavir / therapeutic use
  • Disease Management*
  • Disease Susceptibility
  • HIV Infections / diagnosis*
  • HIV Infections / drug therapy*
  • Heterocyclic Compounds, 3-Ring
  • Heterocyclic Compounds, 4 or More Rings / therapeutic use
  • Humans
  • Male
  • Penis / microbiology
  • Piperazines
  • Pyridones
  • Ritonavir / adverse effects
  • Ritonavir / therapeutic use
  • Treatment Outcome
  • Washington

Substances

  • Amides
  • Anti-HIV Agents
  • Heterocyclic Compounds, 3-Ring
  • Heterocyclic Compounds, 4 or More Rings
  • Piperazines
  • Pyridones
  • bictegravir
  • Ritonavir
  • Darunavir